-
digital.ahrq.gov/technology/fast-healthcare-interoperability-resources-fhir
August 01, 2024 - , hybrid type II trial of interoperable clinical decision support to improve venous thromboembolism prophylaxis … , hybrid type II trial of interoperable clinical decision support to improve venous thromboembolism prophylaxis … Ozaydin, Bunyamin
Implementation of DDInteract: A Shared Decision Making Tool for Anticoagulant … DDInteract, a shared decision making clinical decision support tool that aims to reduce harm from oral anticoagulant
-
digital.ahrq.gov/medical-condition/thromboembolism
January 01, 2024 - , hybrid type II trial of interoperable clinical decision support to improve venous thromboembolism prophylaxis … , hybrid type II trial of interoperable clinical decision support to improve venous thromboembolism prophylaxis … Support System
Implementation of DDInteract: A Shared Decision Making Tool for Anticoagulant … Ronilda
Drug-drug interaction between dexamethasone and direct-acting oral anticoagulants … Drug-drug interaction between dexamethasone and direct-acting oral anticoagulants: A nested case-control
-
digital.ahrq.gov/health-it-tools-and-resources/health-it-costs-and-benefits-database/clinical-decision-support-system
June 07, 2000 - Purpose of Study: Determine whether presentation of venous thromboembolism prophylaxis guidelines using
-
digital.ahrq.gov/ahrq-funded-projects/evaluation-scaled-scaling-acceptable-cds-approach-implementation-interoperable-cds-venous
January 01, 2024 - researchers plan to scale and evaluate the implementation of a CDS tool for venous thromboembolism (VTE) prophylaxis … The researchers plan to widely disseminate this new VTE prophylaxis in TBI tool with U.S. trauma societies … , hybrid type II trial of interoperable clinical decision support to improve venous thromboembolism prophylaxis … , hybrid type II trial of interoperable clinical decision support to improve venous thromboembolism prophylaxis … The researchers plan to widely disseminate this new VTE prophylaxis CDS tool for TBI patients to U.S.
-
digital.ahrq.gov/sites/default/files/docs/transforming-guidelines-action-slides-06152023.pdf
June 15, 2023 - Proportion of admitted patients with pharmacologic VTE
prophylaxis
Proctor’s E et al Adm Policy … Order Set
Open the VTE
Prophylaxis
(Medical) order
set.
45
IMPROVE-DD VTE CDS … Workflow #1:
VTE Prophylaxis Order Set (Cont’d)
Click the
checkbox to
launch the
IMPROVE-DD … An Ideal RAM for DVT Prophylaxis in Medical Inpatients
External Validation of VTE RAMs in Medically … Order Set
IMPROVE-DD VTE CDS Workflow #1: VTE Prophylaxis Order Set (Cont’d)
IMPROVE-DD VTE CDS
-
digital.ahrq.gov/sites/default/files/docs/page/reduction-in-hospital-acquired-complications-and-infections-quick-reference-guide.pdf
January 01, 2010 - can be prevented by following
recommendations of the American College of Chest
Physicians for use of anticoagulants … Use of
antimicrobial prophylaxis for major surgery:
baseline results from the National Surgical
Infection
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs021322-sarkar-final-report-2015.pdf
January 01, 2015 - Over
20 million Americans take warfarin, an anticoagulant, in the ambulatory setting to protect against … thrombosis
Mitral/aortic valve replacement
Hypercoagulation
Pulmonary arterial hypertension
Orthopedic prophylaxis … A Method to Determine the Optimal
Intensity of Oral Anticoagulant Therapy.
-
digital.ahrq.gov/sites/default/files/docs/medication-management-elderly-slides-081811.pdf
August 18, 2011 - 100 120
Drug interactions
Inadequate monitoring
Failure to act on monitoring
Known allergy
No prophylaxis
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017010-bailey-final-report-2011.pdf
January 01, 2011 - previous work we
have shown that ambulatory ADEs related to high-alert medications – particularly anticoagulants … started during
hospitalization may be continued without adequate outpatient monitoring (e.g., oral
anticoagulants … definition: “an effect which is
noxious and unintended, and which occurs at doses used in man for prophylaxis … hazardous
medications that are used heavily in adults, but much less frequently in children – such as
anticoagulants
-
digital.ahrq.gov/sites/default/files/docs/citation/r01hs026732-usher-final-report-2023.pdf
January 01, 2023 - ; 95% CI,
0.66-0.99) and the use of COVID-19–specific therapeutics including deep vein thrombosis
prophylaxis